Evidence map›Paper›PMID 41874027›Full record

ArticleAntibodies (Basel, Switzerland)2026

Developability Evaluation of Single-Domain Antibody-Chelator Conjugates for Diagnostic Radiotracers.

Philipp D Kaiser, Simon Straß, Sandra Maier, Evgenia Herbold, Bjoern Traenkle, Anne Zeck

Abstract read
In one paragraph

Article in Antibodies (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Philipp D KaiserNMI Natural and Medical Sciences Institute, University of Tübingen, 72770 Reutlingen, Germany.ORCID 0009-0003-3517-0341
Simon StraßNMI Natural and Medical Sciences Institute, University of Tübingen, 72770 Reutlingen, Germany.ORCID 0000-0003-3803-6976
Sandra MaierNMI Natural and Medical Sciences Institute, University of Tübingen, 72770 Reutlingen, Germany.
Evgenia HerboldNMI Natural and Medical Sciences Institute, University of Tübingen, 72770 Reutlingen, Germany.
Bjoern TraenkleNMI Natural and Medical Sciences Institute, University of Tübingen, 72770 Reutlingen, Germany.ORCID 0000-0002-6106-4302
Anne ZeckNMI Natural and Medical Sciences Institute, University of Tübingen, 72770 Reutlingen, Germany.ORCID 0000-0001-7330-1654

Funding

European Regional Development Fund Regionlnn_2449401European Regional Development Fund (ERDF) 3-4332.62-NMI/69Federal German Ministry for Economic Affairs and Climate Action (BMWK) 03EFVBW253
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chelatability (Cu2+ radiolabeling efficiency)chelator conjugates (NODAGA)developability assessmentdynamic light scattering (DLS)liquid chromatography-mass spectrometry (LC–MS)nanoDSF (thermal stability)peptide mapping (LC–MS/MS)quantitative Antigen Binding Capacity SEC (qABC-SEC)single-domain antibodies (sdAbs)

Identifiers

PMID41874027
PMCPMC13010638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.